These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21485840)

  • 1. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer.
    Aggarwal S; Yadav S; Gupta S
    J Biomed Nanotechnol; 2011 Feb; 7(1):137-8. PubMed ID: 21485840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
    Allison Logan S; Brissenden AJ; Szewczuk MR; Neufeld RJ
    Drug Des Devel Ther; 2017; 11():2239-2250. PubMed ID: 28814832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy.
    Jaidev LR; Krishnan UM; Sethuraman S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():40-7. PubMed ID: 25492170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies.
    Jamil A; Aamir Mirza M; Anwer MK; Thakur PS; Alshahrani SM; Alshetaili AS; Telegaonkar S; Panda AK; Iqbal Z
    Drug Dev Ind Pharm; 2019 May; 45(5):745-753. PubMed ID: 30632800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-functional nanoparticles as theranostic agents for the treatment & imaging of pancreatic cancer.
    Jaidev LR; Chellappan DR; Bhavsar DV; Ranganathan R; Sivanantham B; Subramanian A; Sharma U; Jagannathan NR; Krishnan UM; Sethuraman S
    Acta Biomater; 2017 Feb; 49():422-433. PubMed ID: 27890622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugate.
    Khare V; Kour S; Alam N; Dubey RD; Saneja A; Koul M; Gupta AP; Singh D; Singh SK; Saxena AK; Gupta PN
    Int J Pharm; 2014 Aug; 470(1-2):51-62. PubMed ID: 24810239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.
    Singh A; Xu J; Mattheolabakis G; Amiji M
    Nanomedicine; 2016 Apr; 12(3):589-600. PubMed ID: 26656632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
    Mondal G; Almawash S; Chaudhary AK; Mahato RI
    Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic targeting/prodrug strategies for intravesical drug delivery--lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer.
    Neutsch L; Wirth EM; Spijker S; Pichl C; Kählig H; Gabor F; Wirth M
    J Control Release; 2013 Jul; 169(1-2):62-72. PubMed ID: 23588390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing for efficient antitumor activity.
    Martín-Banderas L; Sáez-Fernández E; Holgado MÁ; Durán-Lobato MM; Prados JC; Melguizo C; Arias JL
    Int J Pharm; 2013 Feb; 443(1-2):103-9. PubMed ID: 23299085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells.
    Papa AL; Basu S; Sengupta P; Banerjee D; Sengupta S; Harfouche R
    BMC Cancer; 2012 Sep; 12():419. PubMed ID: 22998550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.
    Chitkara D; Kumar N
    Pharm Res; 2013 Sep; 30(9):2396-409. PubMed ID: 23756758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G; Kumar A; Sawant K
    Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs) using central composite design.
    Yalcin TE; Ilbasmis-Tamer S; Takka S
    Int J Pharm; 2018 Sep; 548(1):255-262. PubMed ID: 29969712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UPEC biomimickry at the urothelial barrier: lectin-functionalized PLGA microparticles for improved intravesical chemotherapy.
    Neutsch L; Wambacher M; Wirth EM; Spijker S; Kählig H; Wirth M; Gabor F
    Int J Pharm; 2013 Jun; 450(1-2):163-76. PubMed ID: 23628404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
    Malathi S; Balasubramanian S
    J Biomed Nanotechnol; 2011 Feb; 7(1):150-1. PubMed ID: 21485846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
    Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-Releasing Hormone Loaded and Chitosan Engineered Polymeric Nanoparticles: Towards Effective Delivery of Neuropeptides.
    Kaur S; Bhararia A; Sharma K; Mittal S; Jain R; Wangoo N; Sharma RK
    J Nanosci Nanotechnol; 2016 May; 16(5):5324-32. PubMed ID: 27483926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent.
    Patra CR; Bhattacharya R; Wang E; Katarya A; Lau JS; Dutta S; Muders M; Wang S; Buhrow SA; Safgren SL; Yaszemski MJ; Reid JM; Ames MM; Mukherjee P; Mukhopadhyay D
    Cancer Res; 2008 Mar; 68(6):1970-8. PubMed ID: 18339879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.